title: A US Food and Drug Administration perspective on evaluating medical products for Ebola.
authors.affiliation: Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA estelle.russek-cohen@fda.hhs.gov.
authors.forename: Estelle
authors.initials: E
authors.lastname: Russek-Cohen
authors.affiliation: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Rubin
authors.affiliation: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Dionne
authors.initials: D
authors.lastname: Price
authors.affiliation: Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Wellington
authors.initials: W
authors.lastname: Sun
authors.affiliation: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Edward
authors.initials: E
authors.lastname: Cox
authors.affiliation: Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Luciana
authors.initials: L
authors.lastname: Borio
mesh_terms: D000354:Africa, Western / Q000453:epidemiology; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D017277:Drug Approval / Q000379:methods* / Q000458:organization & administration; D046129:Ebola Vaccines; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000998:Antiviral Agents; D046129:Ebola Vaccines
keywords: Ebola; Therapeutic clinical trials; vaccine clinical trials